Socioeconomic Impact of RSV Hospitalization

Michal Young1, Lynn Smitherman2

  • 1Department of Pediatrics and Child Health, Howard University Hospital, Washington, DC, USA. m_a_young@Howard.edu.

Insights

Respiratory syncytial virus (RSV) causes significant illness and death in young children globally, particularly in developing nations. Identifying sociodemographic risk factors is crucial for managing severe RSV disease and its substantial healthcare burden.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Public Health

Background:

  • Respiratory syncytial virus (RSV) infection is a leading cause of childhood illness and death worldwide, disproportionately affecting developing countries.
  • Severe RSV disease, including lower respiratory tract infections (LRTI), leads to hospitalization, intensive care, and long-term health issues.
  • Sociodemographic factors significantly influence the risk and severity of RSV disease in children.

Purpose of the Study:

  • To review the socioeconomic impact and healthcare resource utilization associated with RSV-related hospitalizations (RSVH).
  • To identify key sociodemographic risk factors for severe RSV disease in children.
  • To inform the consideration of RSV prophylaxis strategies.

Main Methods:

  • This review synthesizes existing literature on RSV disease burden, risk factors, and healthcare utilization.
  • It examines data on hospitalization rates, intensive care admissions, and mortality.
  • The review analyzes sociodemographic variables associated with severe RSV outcomes.

Main Results:

  • RSV poses a substantial global health burden, with most severe cases and mortality occurring in developing countries.
  • Independent risk factors for severe RSV include young age and premature birth.
  • RSV hospitalizations result in significant healthcare resource utilization, long-term complications, and socioeconomic costs for families and healthcare systems.

Conclusions:

  • Understanding sociodemographic risk factors is essential for identifying high-risk children for severe RSV disease.
  • The significant morbidity, mortality, and socioeconomic impact of RSV underscore the need for effective prevention and management strategies.
  • Current prophylaxis options like palivizumab are limited to specific high-risk groups, highlighting the need for broader interventions.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.8K
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
1.1K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
717
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
577
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.0K
Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
2.5K